 |
|
|
| |
Concordance Between SVR4, SVR12, and SVR24 in Genotype 1 HCV-Infected Patients Who Received All Oral Fixed-Dose Combination Ledipasvir/Sofosbuvir With or Without Ribavirin in Phase 3 Clinical Trials
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
David Bernstein,1 Alessandra Mangia,2 Norbert Brau,3 Jenny C. Yang,4 Julie Ma,4 Rob Hyland,4 Phillip S. Pang,4 John G. McHutchison,4 K. Rajender Reddy,5 Michael Fried6
1North Shore University Hospital, Manhasset, NY; 2Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 3Mount Sinai School of Medicine, New York, NY; 4Gilead Sciences, Inc., Foster City, CA; 5University of Pennsylvania, Philadelphia, PA; 6University of North Carolina at Chapel Hill Liver Center, Chapel Hill, NC
|
| |
|
|
|
|
|
